LEADER 03007oam 2200685 450 001 9910704870703321 005 20131125082304.0 035 $a(CKB)5470000002445026 035 $a(OCoLC)857794588 035 $a(EXLCZ)995470000002445026 100 $a20130910d2012 ua 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aDefense $eJoint Strike Fighter Program : agreement between the United States of America and other governments amending the memorandum of understanding of January 17, 2001: signed at Bristol and Washington, February 1 and February 7, 2002; signed at Ottawa and Washington, May 16 and May 28, 2002; signed at Soesterberg Airbase, Washington, Ottawa, and Copenhagen, June 5, June 10, June 17, July 8, and September 17, 2002; signed at Washington, Ottawa, Bristol, and Copenhagen, June 17, June 20, July 8, September 17, and October 14 and November 14, 2002; signed at Washington, Ottawa, Bristol, and Copenhagen, June 17, June 24, July 8, September 17, and October 14 and November 14, 2002; signed at Washington, Bristol, and Copenhagen, July 11, September 17, October 14, and November 14, 2002; signed at Washington, October 31 and November 14, 2002 210 1$a[Washington, D.C.] :$cUnited States Department of State,$d[2012?] 215 $a1 online resource (58 unnumbered pages) 225 1 $aTreaties and other international acts series ;$v02-207.1 300 $aTitle from title screen (viewed on September 10, 2013). 517 $aDefense 606 $aJet planes, Military$zUnited States 606 $aJet planes, Military$zAustralia 606 $aJet planes, Military$zCanada 606 $aJet planes, Military$zDenmark 606 $aJet planes, Military$zGreat Britain 606 $aJet planes, Military$zItaly 606 $aJet planes, Military$zNetherlands 606 $aJet planes, Military$zNorway 606 $aJet planes, Military$zTurkey 606 $aJet fighter planes$xInternational cooperation 606 $aAeronautics, Military$xInternational cooperation 615 0$aJet planes, Military 615 0$aJet planes, Military 615 0$aJet planes, Military 615 0$aJet planes, Military 615 0$aJet planes, Military 615 0$aJet planes, Military 615 0$aJet planes, Military 615 0$aJet planes, Military 615 0$aJet planes, Military 615 0$aJet fighter planes$xInternational cooperation. 615 0$aAeronautics, Military$xInternational cooperation. 712 02$aAustralia, 712 02$aCanada, 712 02$aDenmark, 712 02$aItaly, 712 02$aNetherlands, 712 02$aNorway, 712 02$aTurkey, 712 02$aUnited States, 712 02$aUnited States.$bDepartment of State, 801 0$bGPO 801 1$bGPO 801 2$bGPO 906 $aBOOK 912 $a9910704870703321 996 $aDefense$92306666 997 $aUNINA LEADER 04668nam 2201345z- 450 001 9910557497303321 005 20220111 035 $a(CKB)5400000000042858 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/76590 035 $a(oapen)doab76590 035 $a(oapen)76590 035 $a(EXLCZ)995400000000042858 100 $a20202201d2021 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aAdvances in Lipidomics: Biomedicine, Nutrients and Methodology 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 215 $a1 online resource (248 p.) 311 08$a3-0365-1186-5 311 08$a3-0365-1187-3 330 $aThis book contains 12 articles covering biomedicine, nutrition, and the methodology of lipidomics . These works were first published by MDPI in a Special Issue of Metabolites. Phospholipids, sphingolipids, glyosylinositolphosphoceramides, cholesteryl esters, acyl-carnitines, and oxylipins are within the lipid classes accounted for studies regarding liver disease, Wilson disease, kidney disease, cardiovascular disease, adipogenesis, and the role lipids play in cancer and virus infection. High-throughput lipid extraction and guidelines for lipid annotation are addressed in several papers. This book is expected to provide a comprehensive view of the diverse areas where lipidomics looms largest. 517 $aAdvances in Lipidomics 606 $aResearch & information: general$2bicssc 606 $aResearch and information: general$2bicssc 610 $aadipocytes 610 $aadipogenesis 610 $aadipose tissue 610 $aatopic dermatitis 610 $aautomated annotation 610 $abiomarker 610 $abiomarkers 610 $acancer 610 $acancer cell membranes 610 $acardiovascular disease 610 $acholesterol 610 $achronic kidney disease 610 $acopper 610 $aCOX 610 $aCYP450 610 $adesaturase enzymes 610 $adiabetic cardiomyopathy 610 $adifferential mobility spectrometry (DMS) 610 $adilated cardiomyopathy 610 $adrug-induced liver injury 610 $adry eye disease 610 $aessential fatty acids 610 $afatty acid biomarker 610 $afatty acid biosynthesis 610 $afatty acid signaling 610 $afatty acids 610 $aflow-injection mass-spectrometry 610 $aFolch 610 $aGIPC 610 $aglycolipidomics 610 $aglycosyl inositol phospho ceramides 610 $aheart failure 610 $ahigh-resolution mass spectrometry 610 $ahyperosmolarity 610 $aimmunotherapy 610 $ainflammation 610 $aLC-MS 610 $aleptin 610 $aLipid Data Analyzer 610 $alipid metabolism 610 $alipid profiling 610 $alipidomic 610 $alipidomics 610 $alipids 610 $alipidyzer 610 $aliquid chromatography 610 $aLOX 610 $amass spectrometry 610 $amembrane fusion 610 $ametabolism 610 $ametabolomics 610 $amolecular network 610 $amolecular nutrition 610 $amyocardial infarction 610 $aobesity 610 $aodd chain lipids 610 $aoxylipins 610 $aphenotyping 610 $aphosphatidylinositol 610 $aplasma lipid profiles 610 $apredictive elastic net 610 $aprotein precipitation 610 $aPUFAs 610 $arelative lipid composition (Mol%) 610 $asample preparation 610 $asapienic acid 610 $aSARS-CoV 610 $asebaleic acid 610 $aSHARPIN-deficient mice 610 $aSimpson-Golabi-Behmel syndrome (SGBS) 610 $asphingolipids 610 $assRNA+ virus 610 $atandem mass spectrometry 610 $aultra-high pressure liquid chromatography 610 $aUPLC-MS/MS 610 $aWilson's disease 615 7$aResearch & information: general 615 7$aResearch and information: general 700 $aMontero$b Olimpio$4edt$01312700 702 $aBalgoma$b David$4edt 702 $aGil-de-Gómez$b Luis$4edt 702 $aMontero$b Olimpio$4oth 702 $aBalgoma$b David$4oth 702 $aGil-de-Gómez$b Luis$4oth 906 $aBOOK 912 $a9910557497303321 996 $aAdvances in Lipidomics: Biomedicine, Nutrients and Methodology$93030928 997 $aUNINA